$NASDAQ:ASND

TimesSquare Capital Management LLC reduces stake in Ascendis Pharma A/S by 16% in third quarter
Gallery

TimesSquare Capital Management LLC reduces stake in Ascendis Pharma A/S by 16% in third quarter

🌥️Trending News ASCENDIS PHARMA A/S ($NASDAQ:ASND) is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with [...]

By GoodWhale|November 12, 2024|Categories: Biotechnology|Tags: $NASDAQ:ASND, Biotechnology, NASDAQ|0 Comments

Ascendis Pharma A/S ADR Stock Reigns Supreme in Latest Market Trends
Gallery

Ascendis Pharma A/S ADR Stock Reigns Supreme in Latest Market Trends

☀️Trending News Ascendis ($NASDAQ:ASND) Pharma A/S, a Danish biopharmaceutical company, is currently dominating the market with its ADR (American Depository [...]

By GoodWhale|October 15, 2024|Categories: Biotechnology, Market Forecasts|Tags: $NASDAQ:ASND, Biotechnology, NASDAQ|0 Comments

Cantor Fitzgerald lowers FY2024 earnings forecast for Ascendis Pharma, signaling potential challenges for the biotech company
Gallery

Cantor Fitzgerald lowers FY2024 earnings forecast for Ascendis Pharma, signaling potential challenges for the biotech company

🌧️Trending News ASCENDIS PHARMA A/S ($NASDAQ:ASND) is a biotech company that focuses on developing innovative treatments for rare and chronic [...]

By GoodWhale|October 8, 2024|Categories: Biotechnology|Tags: $NASDAQ:ASND, Biotechnology, NASDAQ|0 Comments

Ascendis Pharma’s TransCon CNP Shows Promising Results in Achondroplasia Trial, Boosting Potential for Growth
Gallery

Ascendis Pharma’s TransCon CNP Shows Promising Results in Achondroplasia Trial, Boosting Potential for Growth

☀️Trending News Ascendis ($NASDAQ:ASND) Pharma A/S is a biopharmaceutical company based in Copenhagen, Denmark that focuses on developing innovative treatments [...]

By GoodWhale|September 18, 2024|Categories: Biotechnology, Profitability|Tags: $NASDAQ:ASND, Biotechnology, NASDAQ|0 Comments

ASND Intrinsic Value Calculation – Jefferies Gives Ascendis Pharma A/S ‘Buy’ Rating, Citing Promising TransCon PTH Market Potential
Gallery

ASND Intrinsic Value Calculation – Jefferies Gives Ascendis Pharma A/S ‘Buy’ Rating, Citing Promising TransCon PTH Market Potential

☀️Trending News Jefferies has initiated coverage of Ascendis ($NASDAQ:ASND) Pharma A/S with a “Buy” rating, citing the company’s promising TransCon [...]

By GoodWhale|December 21, 2023|Categories: Biotechnology, Intrinsic Value, Market Forecasts|Tags: $NASDAQ:ASND, Biotechnology, NASDAQ|0 Comments

FDA Approves Ascendis Pharma A/S Resubmission of TransCon PTH Market Application
Gallery

FDA Approves Ascendis Pharma A/S Resubmission of TransCon PTH Market Application

☀️Trending News Ascendis ($NASDAQ:ASND) Pharma A/S is a global biopharmaceutical company developing innovative and transformative therapies to improve the lives [...]

By GoodWhale|December 13, 2023|Categories: Biotechnology, Market Forecasts|Tags: $NASDAQ:ASND, Biotechnology, NASDAQ|0 Comments

Ascendis Pharma A/S Reports Third Quarter Earnings for Fiscal Year 2023
Gallery

Ascendis Pharma A/S Reports Third Quarter Earnings for Fiscal Year 2023

🌥️Earnings Overview Ascendis ($NASDAQ:ASND) Pharma A/S announced its third quarter of fiscal year 2023 earnings results on November 7, 2023. [...]

By GoodWhale|December 10, 2023|Categories: Biotechnology, Earnings Report|Tags: $NASDAQ:ASND, Biotechnology, NASDAQ|0 Comments

Ascendis Pharma A/S Resubmits NDA for TransCon™ PTH to the U.S. FDA
Gallery

Ascendis Pharma A/S Resubmits NDA for TransCon™ PTH to the U.S. FDA

🌥️Trending News Ascendis ($NASDAQ:ASND) Pharma A/S is a late-stage biopharmaceutical company committed to developing a robust pipeline of long-acting therapies [...]